MCL-1 is a prognostic indicator and drug target in breast cancer

Kirsteen J. Campbell(Cancer Research UK Scotland Institute), Karen Blyth(Cancer Research UK Scotland Institute)
Cell Death and Disease
January 16, 2018
10.1038/s41419-017-0035-2
Cited by 202

Related Papers

Targeting BCL-2 regulated apoptosis in cancer
|Open Biology|2018|538
<i>Runx2</i> and <i>MYC</i> Collaborate in Lymphoma Development by Suppressing Apoptotic and Growth Arrest Pathways <i>In vivo</i>
|Cancer Research|2006|101
The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
|Cells|2023|13